2006 Consumption Epilepsy Treatment 
Project CBD
MARCH 21, 2023
Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.
Cannabis Law Report
MAY 30, 2022
If a rule of criminal law precludes a person from obtaining appropriate medical treatment when his or her life or health is in danger, then the state has intervened and this intervention constitutes a violation of that man’s or that woman’s security of the person …. Publisher: Law Now. MAY 1, 2020 BY PETER BOWAL AND DUSTIN BODNAR.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kind Meds (Cannabis Education Blog)
APRIL 29, 2019
In 2006, three-month-old Charlotte Figi experienced her first seizure, which lasted an exhausting 30 minutes. At the age of three, Charlotte tested positive for a gene marker that indicates Dravet syndrome, a rare form of epilepsy that begins in infant or toddlerhood and causes more severe and more frequent seizures over time.
Cannabis Law Report
JULY 12, 2019
Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). The first study I will reference is from 2006, conducted on mice.
Cannabis Law Report
FEBRUARY 1, 2020
Market research by Cannabis Access Clinics estimates that Australian patients spend an average of A$370/month on medical marijuana products, with epilepsy patients paying an even higher A$1,000/month on average. Research suggests that an estimated 25,000 individuals could qualify for treatment in 2018 alone.
Cannabis Law Report
NOVEMBER 24, 2021
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.
Expert insights. Personalized for you.
144 
Let's personalize your content